Home/Publication/Blackstone to Exit from Alinamin Pharmaceutical
Blackstone to Exit from Alinamin Pharmaceutical 

02 Jul 2024

US$ 19.00

Blackstone Inc is to sell its stake in Alinamin Pharmaceutical Co Ltd (Alinamin Pharmaceutical) to MBK Partners for ¥...

Price / article: US$19.00
OR existing subscriber
Related Publications

Investcorp, Navis Capital Partners and Nexus Point were among the pool of general partners (GPs) selected by by ......

TA Associates has made a strategic investment in Viridian Financial Group (Viridian) for an undisclosed...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.